{
    "ticker": "NUMV",
    "name": "Numinus Wellness Inc.",
    "description": "Numinus Wellness Inc. is a leading company in the emerging field of psychedelic-assisted therapies and mental health solutions. Founded in 2019, Numinus aims to advance the understanding and accessibility of psychedelic treatments for mental health conditions such as depression, anxiety, and PTSD. The company is dedicated to providing safe and supportive environments for individuals seeking healing through innovative therapies. Numinus operates clinics that offer a range of services, including psychotherapy and integration support, and is actively involved in research and development of psychedelic compounds. Their commitment to evidence-based practices ensures that they remain at the forefront of the psychedelic healthcare revolution. With a focus on collaboration, Numinus partners with researchers, healthcare professionals, and organizations to further the study of psychedelics and their therapeutic potential. The company's mission is to transform mental health care by leveraging the power of psychedelics to foster healing and well-being in communities worldwide.",
    "industry": [
        "Healthcare",
        "Pharmaceuticals",
        "Mental Health"
    ],
    "headquarters": "Vancouver, British Columbia, Canada",
    "founded": "2019",
    "website": "https://numinus.ca",
    "ceo": "Payton Nyquvest",
    "social_media": {
        "twitter": "https://twitter.com/numinushealth",
        "linkedin": "https://www.linkedin.com/company/numinushealth/",
        "instagram": "https://www.instagram.com/numinushealth/"
    },
    "investor_relations": "https://numinus.ca/investors/",
    "key_executives": [
        {
            "name": "Payton Nyquvest",
            "position": "CEO"
        },
        {
            "name": "Michael D. D. P. D. C. E. Hughes",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Therapeutic Services",
            "products": [
                "Psychedelic-Assisted Therapy",
                "Integration Support",
                "Psychotherapy"
            ]
        },
        {
            "category": "Research and Development",
            "products": [
                "Psychedelic Research",
                "Clinical Trials"
            ]
        }
    ],
    "seo": {
        "meta_title": "Numinus Wellness Inc. | Pioneering Psychedelic-Assisted Therapy",
        "meta_description": "Explore Numinus Wellness Inc., a leader in psychedelic-assisted therapies and mental health solutions. Discover their innovative approach to healing and well-being.",
        "keywords": [
            "Numinus",
            "Psychedelic Therapy",
            "Mental Health",
            "Wellness",
            "Depression Treatment",
            "Anxiety Treatment"
        ]
    },
    "faq": [
        {
            "question": "What is Numinus known for?",
            "answer": "Numinus is known for its pioneering work in psychedelic-assisted therapies and mental health solutions."
        },
        {
            "question": "Who is the CEO of Numinus?",
            "answer": "Payton Nyquvest is the CEO of Numinus Wellness Inc."
        },
        {
            "question": "Where is Numinus headquartered?",
            "answer": "Numinus is headquartered in Vancouver, British Columbia, Canada."
        },
        {
            "question": "What services does Numinus offer?",
            "answer": "Numinus offers psychedelic-assisted therapy, integration support, and psychotherapy services."
        },
        {
            "question": "When was Numinus founded?",
            "answer": "Numinus was founded in 2019."
        }
    ],
    "competitors": [
        "ATAI",
        "MIND",
        "CMPS"
    ],
    "related_stocks": [
        "TLRY",
        "APHA",
        "CRON"
    ]
}